Robert Dichmann
Impact in
-
- Multiple Myeloma Research and Treatments
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 4
-
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Ralph V. Boccia (4 shared papers)Robert Vescio (4 shared papers)Regina A. Swift (4 shared papers)Ori Yellin (2 shared papers)Dipti Patel‐Donnelly (4 shared papers)James Hilger (4 shared papers)James R. Berenson (4 shared papers)Youram Nassir (4 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Leukemia (1 paper)Therapeutic Advances in Medical Oncology (1 paper)Cancer Research (1 paper)Blood (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Robert Dichmann
9 papers receiving 145 citations
Peers
Comparison fields: 5 of 29
- Hematology 52
- Oncology 103
- Genetics 15
- Cancer Research 21
- Pulmonary and Respiratory Medicine 32
Countries citing papers authored by Robert Dichmann
This map shows the geographic impact of Robert Dichmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dichmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dichmann more than expected).
Fields of papers citing papers by Robert Dichmann
This network shows the impact of papers produced by Robert Dichmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dichmann. The network helps show where Robert Dichmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Dichmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 55 | |
| 2 | 2009 | 37 | |
| 3 | 2018 | 25 | |
| 4 | 2006 | 17 | |
| 5 | 2012 | 5 | |
| 6 | 2011 | 4 | |
| 7 | 2013 | 2 | |
| 8 | 2012 | 1 | |
| 9 | 2014 | 1 |
About Robert Dichmann
Robert Dichmann is a scholar working on Oncology, Hematology, Infectious Diseases, Molecular Biology and Pathology and Forensic Medicine, having authored 9 papers that have together received 147 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Multiple Myeloma Research and Treatments (4 papers), HER2/EGFR in Cancer Research (4 papers), HIV/AIDS drug development and treatment (3 papers), Advanced Breast Cancer Therapies (2 papers), Protein Degradation and Inhibitors (2 papers), Breast Cancer Treatment Studies (2 papers) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (52 citations), Oncology (103 citations), Genetics (15 citations), Cancer Research (21 citations) and Pulmonary and Respiratory Medicine (32 citations). Robert Dichmann has collaborated with scholars based in United States and France. Frequent co-authors include Ralph V. Boccia, Robert Vescio, Regina A. Swift, Ori Yellin, Dipti Patel‐Donnelly, James Hilger, James R. Berenson, Youram Nassir, Sara A. Hurvitz and Mark D. Pegram. Their work appears in journals such as Journal of Clinical Oncology, Leukemia, Therapeutic Advances in Medical Oncology, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.